CEO SUMMARY: Despite much success and milestones at Specialty Laboratories during the past 36 months, it has yet to achieve the most important goal of all: net profits. One reason is familiar to all laboratory administrators and pathologists: with its existing fixed overhead and cost structure, Specialty Labsâ key goal is to increase specimen volume […]
Profit Squeeze Pressures Specialty Laboratories
Growth in revenue & specimen volumes still not enough to generate net profits
- By Robert Michel
- > From the Volume XII No. 4 - March 7, 2005 Issue
